Erratum: Zinc and liver disease (Nutrition in Clinical Practice (2012) 27 (8-20) DOI:10.1177/0884533611433534);Zinc and liver disease

Nutrition in Clinical Practice

Volumn 27, Issue 1, 2012, Pages 8-20

  Mohommad, Mohammad K ^a   Zhou, Zhanxiang ^b   Cave, Matthew ^c   Barve, Ashutosh ^c   McClain, Craig J ^c  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

^c UNIVERSITY OF LOUISVILLE HOSPITAL   (United States)

Author keywords

alcoholic; hepatitis; liver cirrhosis; liver diseases; zinc

Indexed keywords

COPPER; CYTOKINE; GLUTAMATE AMMONIA LIGASE; GLUTATHIONE; HORSERADISH PEROXIDASE; I KAPPA B KINASE BETA; LACTULOSE; MACROGOL; MANNITOL; METALLOTHIONEIN; PREALBUMIN; RETINOL; RETINOL BINDING PROTEIN; RETINOL DEHYDROGENASE; SOMATOMEDIN C; THYMUS HORMONE; TUMOR NECROSIS FACTOR ALPHA; ZINC; ZINC TRANSPORTER;

ACNE; ACRODERMATITIS; ACRODERMATITIS ENTEROPATHICA; ALCOHOL LIVER DISEASE; ALOPECIA; ANOREXIA; APOPTOSIS; BRAIN DISEASE; CELL DEATH; CELL GROWTH; CELLULAR IMMUNITY; CLINICAL TRIAL (TOPIC); CYTOKINE PRODUCTION; DANDRUFF; DIAPER DERMATITIS; DIARRHEA; DIETARY INTAKE; ENDOTOXEMIA; EYE DISEASE; FAILURE TO THRIVE; FIBROSIS; GENE EXPRESSION; GENE MUTATION; HEPATIC ENCEPHALOPATHY; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYPERAMMONEMIA; HYPOGONADISM; INFECTION; LIBIDO DISORDER; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER FUNCTION; LIVER REGENERATION; MEAL; MENTAL FUNCTION; MENTAL HEALTH; NAUSEA; NIGHT VISION; OXIDATIVE STRESS; PARENTERAL NUTRITION; REVIEW; SEPSIS; SKIN DEFECT; SMELLING DISORDER; SPERMATOGENESIS; SPERMATOZOON COUNT; SPERMATOZOON MOTILITY; T LYMPHOCYTE; TASTE DISORDER; THYMUS ATROPHY; URINARY EXCRETION; VIRUS HEPATITIS; WEIGHT REDUCTION; WILSON DISEASE; WOUND HEALING IMPAIRMENT; ZINC DEFICIENCY; ZINC METABOLISM;

HEPATITIS C VIRUS;

EID: 84863073947     PISSN: 08845336     EISSN: 19412452     Source Type: Journal    
DOI: 10.1177/0884533612441470     Document Type: Erratum

References (146)

1. Vallee BL, Wacker WEC, Bartholomay AF, Robin ED. Zinc metabolism in hepatic dysfunction, I: serum zinc concentrations in Laennec's cirrhosis and their validation by sequential analysis. N Engl J Med. 1956 ; 255: 403-408
2. Vallee BL, Wacker WEC, Batholomay AF, Hoch FL. Zinc metabolism in hepatic dysfunction, II: correlation of metabolic patterns with biochemical findings. N Engl J Med. 1956 ; 257: 1056-1065
3. Kahn AM, Helwig HL, Redeker AG, Reynolds TB. Urine and serum zinc abnormalities in disease of the liver. Am J Clin Pathol. 1965 ; 44: 426-435
4. Sullivan JF, Heaney RP. Zinc metabolism in alcoholic liver disease. Am J Clin Nutr. 1970 ; 23: 170-177
5. Walker BE, Dawson JB, Kelleher J, Losowsky MS. Plasma and urinary zinc in patients with malabsorption syndromes or hepatic cirrhosis. Gut. 1973 ; 14: 943-948
6. Kiilerich S, Dietrichson O, Lous FB, et al. Zinc depletion in alcoholic liver diseases. Scand J Gastroenterol. 1980 ; 15: 363-367 (Pubitemid 10124197)
7. McClain CJ, Su L-C. Zinc deficiency in the alcoholic. Alcohol Clin Exp Res. 1984 ; 7: 5-10
8. Kang YJ, Zhou Z. Zinc prevention and treatment of alcoholic liver disease. Mol Aspects Med. 2005 ; 26 (4-5). 391-404 (Pubitemid 41225361)
9. Wang J, Pierson RN. Distribution of zinc in skeletal muscle and liver tissue in normal and dietary controlled alcoholic rats. J Lab Clin Med. 1975 ; 85: 50-58
10. Barak AJ, Beckenhauer HC, Kerrigah FJ. Zinc and manganese levels in serum and liver after alcohol feeding and development of fatty cirrhosis in rats. Gut. 1967 ; 8: 454-457
11. Kahn AM, Ozeran RS. Liver and serum zinc abnormalities in rats with cirrhosis. Gastroenterology. 1967 ; 53: 193-197
12. McClain CJ, Antonow DR, Cohen DA, Shedlofsky SI. Zinc metabolism in alcoholic liver disease. Alcohol Clin Exp Res. 1986 ; 10: 582-589 (Pubitemid 17226976)
13. Gaetke L, McClain CJ, Talwalkar R, Shedlofsky S. Effects of endotoxin on zinc metabolism in human volunteers. Am J Physiol. 1997 ; 272: E952 - E956
14. McClain CJ, McClain ML, Boosalis MG, Hennig B. Zinc and the stress response. Scand J Work Environ Health. 1993 ; 19: 132-133 (Pubitemid 24052158)
15. Bibi Nitzan Y, Cohen AD. Zinc in skin pathology and care. J Dermatolog Treat. 2006 ; 17 (4). 205-210 (Pubitemid 44395544)
16. Moynahan EJ. Acrodermatitis enteropathica: a lethal inherited human zinc deficiency disorder. Lancet. 1973 ; 2: 399-400
17. Wirsching L. Eye symptoms in acrodermatitis enteropathica. Acta Ophthalmol (Copenh). 1962 ; 40: 567-574
18. Acrodermatitis enteropathica: hereditary zinc deficiency. Nutr Rev. 1975 ; 33: 327-329
19. Park CH, Lee MJ, Kim HJ, Lee G, Park JW, Cinn YW. Congenital zinc deficiency from mutations of the SLC39A4 gene as the genetic background of acrodermatitis enteropathica. J Korean Med Sci. 2010 ; 25 (12). 1818-1820
20. McClain CJ, Soutor C, Steele N, Levine AS, Silvis SE. Severe zinc deficiency presenting with acrodermatitis during hyperalimentation: diagnosis, pathogenesis and treatment. J Clin Gastroenterol. 1980 ; 2: 125-131 (Pubitemid 10082973)
21. McClain CJ. Trace metal abnormalities in adults during hyperalimentation. JPEN J Parenter Enteral Nutr. 1981 ; 5: 424-429
22. Ecker RI, Schroeter AL. Acrodermatitis and acquired zinc deficiency. Arch Dermatol. 1978 ; 114: 937-939 (Pubitemid 9202408)
23. Weismann K, Roed-Petersen J, Hjorth N, Kopp H. Chronic zinc deficiency syndrome in a beer drinker with a Billroth II resection. Int J Dermatol. 1976 ; 15: 757-761 (Pubitemid 8004871)
24. Weismann K, Hoyer H, Christensen E. Acquired zinc deficiency in alcoholic liver cirrhosis: report of two cases. Acta Dermat Venereal (Stockh). 1980 ; 60: 447-449 (Pubitemid 11225026)
25. Najarian DJ, Majarian JS, Rao BK, Pappert AS. Hypozincemia and hyperzincuria associated with necrolytic acral erythema. Int J Dermatol. 2008 ; 47: 709-711 (Pubitemid 352016086)
26. Tabibian JH, Gerstenblith MR, Tedford RJ, Junkins-Hopkins JM, Abuav R. Necrolytic acral erythema as a cutaneous marker of hepatitis C: report of two cases and review. Dig Dis Sci. 2010 ; 55 (10). 2735-2743
27. Patel U, Loyd A, Patel R, Meehan S, Kundu R. Necrolytic acral erythema. Dermatol Online J. 2010 ; 16 (11). 15
28. Henkin RI, Patten BM, Re PK, Bronzert DA. A syndrome of acute zinc loss: cerebellar dysfunction, mental changes, anorexia, and taste and smell dysfunction. Arch Neurol. 1975 ; 32 (11). 745-751
29. McClain CJ, Zieve L Problems in Liver Disease. David CS, ed. New York, NY: Grune and Stratton ; 162-173.
30. Bismuth M, Funakoshi N, Cadranel JF, Blanc P. Hepatic encephalopathy: from pathophysiology to therapeutic management. Eur J Gastroenterol Hepatol. 2011 ; 23 (1). 8-22
31. Butterworth RF. Complications of cirrhosis, III: hepatic encephalopathy. J Hepatol. 2000 ; 32 (1). 171-180 (Pubitemid 30123633)
32. Grngreiff K, Abicht K, Kluge M, et al. Clinical studies on zinc in chronic liver diseases. Z Gastroenterol. 1988 ; 26 (8). 409-415
33. Rahelicć D, Kujundzicć M, Romicć Z, Brkicć K, Petrovecki M. Serum concentration of zinc, copper, manganese and magnesium in patients with liver cirrhosis. Coll Antropol. 2006 ; 30 (3). 523-528 (Pubitemid 44519499)
34. Rabbani P, Prasad A. Plasma ammonia and liver ornithine transcarbamoylase activity in zinc-deficient rats. Am J Physiol. 1978 ; 235: E203 - E206
35. Dejong CH, Deutz NE, Soeters PB. Muscle ammonia and glutamine exchange during chronic liver insufficiency in the rat. J Hepatol. 1994 ; 21: 299-307 (Pubitemid 24308750)
36. Görg B, Qvartskhava N, Bidmon HJ, et al. Oxidative stress markers in the brain of patients with cirrhosis and hepatic encephalopathy. Hepatology. 2011 ; 54 (1). 204-215
37. Takuma Y, Nouso K, Makino Y, Hayashi M, Takahashi H. Clinical trial: oral zinc in hepatic encephalopathy. Aliment Pharmacol Ther. 2010 ; 32 (9). 1080-1090
38. Van der Rijt CC, Schalm SW, Schat H, Foeken K, DeJong G. Overt hepatic encephalopathy precipitated by zinc deficiency. Gastroenterology. 1991 ; 100 (4). 1114-1118
39. Patek AJ, Haig C. The occurrence of abnormal dark adaptation and its relation to vitamin A metabolism in patients with cirrhosis of the liver. J Clin Invest. 1939 ; 18: 609-616
40. Abbott-Johnson WJ, Kerlin P, Abiad G, Claque AE, Cuneo RC. Dark adaptation in vitamin A-deficient adults awaiting liver transplantation: improvement with intramuscular vitamin A treatment. Br J Ophthalmol. 2011 ; 95 (4). 544-548
41. Barber C, Brimlow G, Galloway NR, Toghill P, Walt RP. Dark adaptation compared with electrooculography in primary biliary cirrhosis. Doc Ophthalmol. 1989 ; 71 (4). 397-402 (Pubitemid 19219278)
42. McClain CJ, Van Thiel DH, Parker S, Badzin LK, Gilbert H. Alterations in zinc, vitamin A, and retinol-binding protein in chronic alcoholism: a possible mechanism for night blindness and hypogonadism. Alcohol Clin Exp Res. 1979 ; 3: 135-141 (Pubitemid 9175432)
43. Morrison SA, Russell RM, Carney EA, Oaks EV. Zinc deficiency: a cause of abnormal dark adaptation in cirrhotics. Am J Clin Nutr. 1978 ; 31: 276-281 (Pubitemid 8302210)
44. Leure-DuPree AE, McClain CJ. The effect of severe zinc deficiency on the morphology of the rat retinal pigment epithelium. Invest Ophthalmol Vis Sci. 1982 ; 23: 425-434 (Pubitemid 12000557)
45. Leure-DuPree AE, Bridges CD. Changes in retinal morphology and vitamin A metabolism as a consequence of decreased zinc availability. Retina. 1982 ; 2 (4). 294-302 (Pubitemid 13113142)
46. Cameron JD, McClain CJ. Ocular histopathology of acrodermatitis enteropathica. Br J Ophthalmol. 1986 ; 70: 662-667 (Pubitemid 16053209)
47. Essatara MB, Levine AS, Morley JE, McClain CJ. Zinc deficiency and anorexia in rats: normal feeding patterns and stress induced feeding. Pharmacol Biochem Behav. 1984 ; 32: 469-474 (Pubitemid 14148122)
48. Henkin RI, Graziadei PPG, Bradley DF. The molecular basis of taste and its disorders. Ann Int Med. 1969 ; 71: 791-819
49. Reeves PG, O'Dell BL. Short-term zinc deficiency in the rat and self-selection of dietary protein level. J Nutr. 1981 ; 111: 375-383 (Pubitemid 11148439)
50. Essatara MB, Levine AS, Morley JE, McClain CJ. Zinc deficiency and anorexia in rats: effect of central administration of norepinephrine, muscimol and bromergocryptine. Pharmacol Biochem Bheav. 1984 ; 32: 479-482 (Pubitemid 14148124)
51. Bettger WJ, O'Dell BL. A critical physiological role of zinc in the structure and function of biomembranes. Life Sci. 1981 ; 28: 1625-1638
52. Mendenhall CL, Anderson S, Weesner RE, Goldberg SJ, Crolic KA. Protein- calorie malnutrition associated with alcoholic hepatitis. Am J Med. 1984 ; 76: 211-222
53. Antonow DR, McClain CJ Alcohol and the Brain. Tarter RE Thiel DH, ed. New York, NY: Plenum ; 81-120.
54. Burch RE, Sackin DA, Ursick JA, Jetton MM, Sullivan JR. Decreased taste and smell acuity in cirrhosis. Arch Int Med. 1978 ; 138: 743-746 (Pubitemid 9011746)
55. Smith FR, Henkin RI, Dell RB. Disordered gustatory acuity in liver disease. Gastroenterology. 1976 ; 70: 568-571
56. Prasad AS. Impact of the discovery of human zinc deficiency on health. J Am Coll Nutr. 2009 ; 28 (3). 257-265
57. Van Thiel DH, Gavaler JS, Schade RR. Liver disease and the hypothalamic pituitary gonadal axis. Semin Liver Dis. 1985 ; 5: 35-45
58. McClain CJ, Gavaler JS, Van Thiel DH. Hypogonadism in the zinc-deficient rat: localization of the functional abnormalities. J Lab Clin Med. 1984 ; 104: 1007-1015 (Pubitemid 15091144)
59. Abbasi AA, Prasad AS, Ortega J, Congco E, Oberleas D. Gonadal function abnormalities in Sickle cell anemia: studies in adult male patients. Ann Int Med. 1976 ; 85: 601-605
60. Prasad AS, Mantzoros CS, Beck FW, Hess JW, Brewer GJ. Zinc status and serum testosterone levels of healthy adults. Nutrition. 1996 ; 12 (5). 344-348 (Pubitemid 26294996)
61. Kumari D, Nair N, Bedwal RS. Effect of dietary zinc deficiency on testes of Wistar rats: morphometric and cell quantification studies. J Trace Elem Med Biol. 2010 ; 25 (1). 47-53
62. Croxford TP, McCormick NH, Kelleher SL. Moderate zinc deficiency reduces testicular Zip6 and Zip10 abundance and impairs spermatogenesis in mice. J Nutr. 2011 ; 141 (3). 359-365
63. Pories WJ, Henzel JH, Rob CG, Strain WH. Acceleration of healing with zinc sulfate. Ann Surg. 1967 ; 167: 432-436
64. Hallböök T, Lanner E. Serum-zinc and healing of venous leg ulcers. Lancet. 1972 ; 2 (7781). 780-782
65. Sandstead HH, Lanier VC, Shephard GH, Gillespie DD. Zinc and wound healing. Am J Clin Nutr. 1970 ; 23: 514-519
66. Watanabe T, Arakawa T, Fukuda T, Higushi K, Kobayashi K. Zinc deficiency delays gastric ulcer healing in rats. Dig Dis Sci. 1995 ; 40 (6). 1340-1344
67. Cherian MG, Kang YJ. Metallothionein and liver cell regeneration. Exp Biol Med (Maywood). 2006 ; 231 (2). 138-144 (Pubitemid 43213450)
68. Oliver JR, Mara TW, Cherian MG. Impaired hepatic regeneration in metallothionein-I/II knockout mice after partial hepatectomy. Exp Biol Med (Maywood). 2005 ; 230 (1). 61-67 (Pubitemid 40041073)
69. Weston WL, Hutt JC, Humbert JR, Hambidge KM, Neldner KH, Walravens PA. Zinc correction of defective chemotaxis in acrodermatitis enteropathica. Arch Dermatol. 1977 ; 113: 422-425 (Pubitemid 8071600)
70. Golden MHN, Jackson AA, Golden BE. Effect of zinc on thymus of recently malnourished children. Lancet. 1977 ; 2: 1057-1059 (Pubitemid 8206874)
71. Allen JI, Kay NE, McClain CJ. Severe zinc deficiency in humans: association with a reversible T-lymphocyte dysfunction. Ann Int Med. 1981 ; 95: 154-157 (Pubitemid 11039816)
72. John E, Laskow TC, Buchser WJ, et al. Zinc in innate and adaptive tumor immunity. J Trans Med. 2010 ; 8: 118-134
73. Lichten LA, Cousins RJ. Mammalian zinc transporters: nutritional and physiologic regulation. Annu Rev Nutr. 2009 ; 29: 153-176
74. Prasad AS. Zinc in human health: effect of zinc on immune cells. Mol Med. 2008 ; 14 (5-6). 353-357 (Pubitemid 351785709)
75. Bao S, Liu M-J, Lee B, et al. Zinc modulates the innate immune response in vivo to polymicrobial sepsis through regulation of NF-kappaB. Am J Physiol Lung Cell Mol Physiol. 2010 ; 298 (6). L744 - L754
76. Wong HR, Shanley TP, Sakthivel B, et al. Genome-level expression profiles in pediatric septic shock indicate a role for altered zinc homeostasis in poor outcome. Physiol Genomics. 2007 ; 30: 146-155 (Pubitemid 47173278)
77. Fukada T, Yamasaki S, Nishida K, Murakami M, Hirano T. Zinc homeostasis and signaling in health and disease. J Biol Inorg Chem. 2011 ; 16 (7). 1123-1134
78. Wang X, Zhou B. Dietary zinc absorption: a play of Zips and ZnTs in the gut. Life. 2010 ; 62 (3). 176-182
79. King JC. Zinc: an essential but elusive nutrient. Am J Clin Nutr. 2011 ; 94: 679S - 684S
80. Kim WR, Brown RS, Terrault NA, El-Serag H. Burden of liver disease in the United States: summary of a workshop. Hepatology ; 2002 ; 2002. 227.
81. Beier JI, Arteel GE, McClain CJ. Advances in alcoholic liver diseases. Curr Gastrol Rep. 2011 ; 13 (1). 56-64
82. Beier JI, McClain CJ. Mechanisms and cell signaling in alcoholic liver disease. Biol Chem. 2010 ; 391 (11). 1249-1264
83. Purohit V, Bode JC, Bode C, et al. Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium. Alcohol ; 2008 ; 2008. 349.
84. Godde HF, Kelleher J, Walker BE. Relation between zinc status and hepatic functional reserve in patients with liver disease. Gut. 1990 ; 31: 694-697 (Pubitemid 20209043)
85. Rodriguez-Moreno F, Gonzalez-Reimers E, Santolaria-Fernandez F, et al. Zinc, copper, mangan3ese, and iron in chronic alcoholic liver disease. Alcohol. 1997 ; 14: 39-44 (Pubitemid 27052108)
86. Zhong W, Zhao Y, McClain CJ, Kang YJ, Zhou Z. Inactivation of hepatocyte nuclear factor-4 {alpha} mediates alcohol-induced down-regulation of intestinal tight junction proteins. Am J Physiol Gastrointest Liver Physiol. 2010 ; 299 (3). G645 - G651
87. Kang X, Liu J, Zhong W, et al. Zinc supplementation reverses alcoholic steatosis in mice through reactivating hepatocyte nuclear factor 4alpha and peroxisome proliferators activated receptor-alpha. Hepatology. 2009 ; 50 (4). 1241-1250
88. Zhou Z, Kang X, Jiang Y, et al. Preservation of hepatocyte nuclear factor-4alpha is associated with zinc protection against TNF-alpha hepatotoxicity in mice. Exp Biol Med (Maywood). 2007 ; 232 (5). 622-628 (Pubitemid 46683387)
89. Kang X, Song Z, McClain CJ, Kang YJ, Zhou Z. Zinc supplementation enhances hepatic regeneration by preserving hepatocyte nuclear factor-4alpha in mice subjected to long-term ethanol administration. Am J Pathol. 2008 ; 172 (4). 916-925 (Pubitemid 351519989)
90. Zhou Z, Liu J, Song Z, McClain CJ, Kang YJ. Zinc supplementation inhibits hepatic apoptosis in mice subjected to long-term ethanol exposure. Exp Biol Med (Maywood). 2008 ; 223 (5). 540-548 (Pubitemid 351657355)
91. Bjarnason I, Peters TJ, Wise RJ. The leaky gut of alcoholism: possible route of entry for toxic compounds. Lancet. 1982 ; 1 (8370). 179-182 (Pubitemid 14221988)
92. Keshavarzian A, Fields JZ, Vaeth J, Holmes EW. The differing effects of acute and chronic alcohol on gastric and intestinal permeability. Am J Gastroenterol. 1994 ; 89: 2205-2211 (Pubitemid 24363671)
93. Keshavarzian A, Choudhary S, Holmes EW, et al. Preventing gut leakiness by oats supplementation ameliorates alcohol-induced liver damage in rats. J Pharmacol Exp Ther. 2001 ; 299: 442-448 (Pubitemid 32979654)
94. Parlesak A, Schafer C, Schutz T, Bode JC, Bode C. Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. J Hepatol. 2000 ; 32: 742-747 (Pubitemid 30262733)
95. Enomoto N, Takei Y, Hirose M, et al. Thalidomide prevents alcoholic liver injury in rats through suppression of Kupffer cell sensitization, and TNF-alpha production. Gastroenterology. 2002 ; 123: 291-300 (Pubitemid 34747549)
96. Forsyth CB, Farhadi A, Jakate SM, Tang Y, Shaikh M, Keshavarzian A. Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis. Alcohol. 2009 ; 43: 163-172
97. Keshavarzian A, Choudhary S, Holmes DW, et al. Preventing gut leakiness by oats supplementation ameliorates alcohol-induced liver damage in rats. J Pharmacol Exp Ther. 2001 ; 299: 442-448 (Pubitemid 32979654)
98. Keshavarzian A, Farhadi A, Forsyth CB, et al. Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats. J Hepatol. 2009 ; 50: 538-547
99. Lambert JC, Zhou Z, Wang L, Song Z, McClain CJ, Kang YJ. Prevention of alterations in intestinal permeability is involved in zinc inhibition of acute ethanol-induced liver damage in mice. J Pharmacol Exp Ther. 2003 ; 305: 880-886 (Pubitemid 36617964)
100. Zhong W, McClain CJ, Cave M, Kang YJ, Zhou Z. The role of zinc deficiency in alcohol-induced intestinal barrier dysfunction. Am J Physiol Gastrointest Liver Physiol. 2010 ; 298 (5). G625 - G633
101. Zhou Z, Wang L, Song Z, Saari JT, McClain CJ, Yang YJ. Zinc supplementation prevents alcoholic liver injury in mice through attenuation of oxidative stress. Am J Pathol. 2005 ; 166: 1681-1690 (Pubitemid 40734391)
102. Zarski JP, Arnaud J, Labadie H, Beaugrand M, Favier A, Rachail M. Serum and tissue concentrations of zinc after oral supplementation in chronic alcoholics with or without cirrhosis. Gastroenterol Clin Biol. 1987 ; 11: 856-860
103. Bianchi GP, Marchesini G, Brizi M, et al. Nutritional effects of oral zinc supplementation in cirrhosis. Nutr Res. 2000 ; 20: 1079-1089 (Pubitemid 30662678)
104. Rosen HR. Chronic hepatitis C infection. N Engl J Med. 2011 ; 364: 2429-2438
105. Grüngreiff K, Reinhold D. Zinc: a complementary factor in the treatment of chronic hepatitis C. Mol Med Report. 2010 ; 3 (3). 371-375
106. Moneib HA, Salem SA, Darwish MM. Evaluation of zinc level in skin of patients with encrolytic acral erythema. Br J Dermatol. 2010 ; 163 (3). 476-480
107. Himoto T, Hosomi N, Nakai S, et al. Efficacy of zinc administration in patients with hepatitis C virus-related chronic liver disease. Scand J Gastroenterol. 2007 ; 42 (9). 1078-1087 (Pubitemid 47301142)
108. Kalkan A, Bulut V, Avci S, Celik I, Bingol NK. Trace elements in viral hepatitis. J Trace Elem Med Biol. 2002 ; 16 (4). 227-230 (Pubitemid 36024952)
109. Yuasa K, Naganuma A, Sato K, et al. Zinc is a negative regulator of hepatitis C virus RNA replication. Liver Int. 2006 ; 26 (9). 1111-1118 (Pubitemid 44541752)
110. Takagi H, Nagamine T, Abe T, et al. Zinc supplementation enhances the response to interferon therapy in patients with chronic hepatitis C. J Viral Hepat. 2001 ; 8 (5). 367-371 (Pubitemid 34205890)
111. Nagamine T, Takagi H, Takayama H, et al. Preliminary study of combination therapy with interferon-alpha and zinc in chronic hepatitis C patients with genotype 1b. Biol Trace Elem Res. 2000 ; 75 (1-3). 53-63 (Pubitemid 30470254)
112. Kim KI, Kim SR, Sasase N, et al. Blood cell, liver function, and response changes by PEG-interferon-alpha2b plus ribavirin with polaprezinc therapy in patients with chronic hepatitis C.. 2008 ; 2 (1). 111-115
113. Ko WS, Guo CH, Hsu GS, Chiou YL, Yeh MS, Yaun SR. The effect of zinc supplementation on the treatment of chronic hepatitis C patients with interferon and ribavirin. Clin Biochem. 2005 ; 38 (7). 614-620
114. Murakami Y, Koyabu T, Kawashima A, et al. Zinc supplementation prevents the increase of transaminase in chronic hepatitis C patients during combination therapy with pegylated interferon alpha-2b and ribavirin. J Nutr Sci Vitaminol (Tokyo). 2007 ; 53 (3). 213-218 (Pubitemid 47217217)
115. Suzuki H, Takagi H, Sohara N, et al. Triple therapy of interferon and ribavirin with zinc supplementation for patients with chronic hepatitis C: a randomized controlled clinical trial. World J Gastroenterol. 2006 ; 12 (8). 1265-1269
116. Matsuoka S, Matsumura H, Nakamura H, et al. Zinc supplementation improves the outcome of chronic hepatitis C and liver cirrhosis. J Clin Biochem Nutr. 2009 ; 45 (3). 292-303
117. Fota-Markowska H, Przybyla A, Borowicz I, Modrzewska R. Serum zinc (Zn) level dynamics in blood serum of patients with acute viral hepatitis B and early recovery period. Ann Univ Mariae Curie Sklodowska Med. 2002 ; 57 (2). 201-209
118. Ozbal E, Helvaci M, Kasirga E, Akdenizoǧlu F, Kizilgneşler A. Serum zinc as a factor predicting response to interferon-alpha2b therapy in children with chronic hepatitis B. Biol Trace Elem Res. 2002 ; 90 (1-3). 31-38 (Pubitemid 36110739)
119. Hoeksema KA, Tyrrell DL. Inhibition of viral transcription using designed zinc finger proteins. Methods Mol Biol. 2010 ; 649: 97-116
120. Ozgenc F, Aksu G, Kirkpinar F, et al. The influence of marginal zinc deficient diet on post-vaccination immune response against hepatitis B in rats. Hepatol Res. 2006 ; 35 (1). 26-30
121. Hoogenraad TU. Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice. Brain Dev. 2006 ; 28 (3). 141-146 (Pubitemid 43326232)
122. Brewer GJ, Dick RD, Yuzbasiyan-Gurkan V, Johnson V, Wang Y. Treatment of Wilson's disease with zinc, XIII: therapy with zinc in presymptomatic patients from the time of diagnosis. J Lab Clin Med. 1994 ; 123 (6). 849-858
123. Huster D. Wilson disease. Best Pract Res Clin Gastroenterol. 2010 ; 24 (5). 531-539
124. Weiss KH, Gotthardt DN, Klemm D, et al. Zinc monotherapy is not as effective as chelating agents in treatment of Wilson Disease. Gastroenterology. 2011 ; 140: 1189-1198
125. Schilsky M. Zinc treatment for symptomatic Wilson disease: moving forward by looking back. Hepatology. 2009 ; 50 (5). 1341-1343
126. Roberts EA. Zinc treatment for symptomatic Wilson disease: moving forward by looking back. Gastroenterology. 2011 ; 140 (4). 1132-1135
127. Hepatocellular carcinoma-United States, 2001-2006. MMWR Morb Mortal Wkly Rep. 2010 ; 59 (17). 517-520
128. Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol. 2009 ; 27: 1485-1491
129. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006 ; 45: 529-538 (Pubitemid 44307383)
130. Morgan TR, Mandayam S, Jamal MM. Alcohol and hepatocellular carcinoma. Gastroenterology. 2004 ; 127: S87 - S96
131. Poo JL, Rosas-Romero R, Montemayor AC, Isoard F, Uribe M. Diagnostic value of the copper/zinc ratio in hepatocellular carcinoma: a case control study. J Gastroenterol. 2003 ; 38 (1). 45-51 (Pubitemid 36267694)
132. Nakayama A, Fukuda H, Ebara M, Hamasaki H, Nakajima K, Sakurai H. A new diagnostic method for chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma based on serum metallothionein, copper, and zinc levels. Biol Pharm Bull. 2002 ; 25 (4). 426-431 (Pubitemid 40036730)
133. Tashiro H, Kawamoto T, Okubo T, Koide O. Variation in the distribution of trace elements in hepatoma. Biol Trace Elem Res. 2003 ; 95 (1). 49-63 (Pubitemid 37386647)
134. Maeda T, Shimada M, Harimoto N, et al. Role of tissue trace elements in liver cancers and non-cancerous liver parenchyma. Hepatogastroenterology. 2005 ; 52 (61). 187-190 (Pubitemid 40282662)
135. Danielsen A, Steinnes E. A study of some selected trace elements in normal and cancerous tissue by neutron activation analysis. J Nucl Med. 1970 ; 11: 260-264
136. Ebara M, Fukuda H, Hatano R, et al. Relationship between copper, zinc and metallothionein in hepatocellular carcinoma and its surrounding liver parenchyma. J Hepatol. 2000 ; 33: 415-422 (Pubitemid 30663379)
137. Liaw KY, Lee PH, Wu FC, Tsai JS, Lin-Shiau SY. Zinc, copper, and superoxide dismutase in hepatocellular carcinoma. Am J Gastroenterol. 1997 ; 92: 2260-2263
138. Tashiro H, Kawamoto T, Okubo T, Koide O. Variation in the distribution of trace elements in hepatoma. Biol Trace Elem Res. 2003 ; 95: 49-63 (Pubitemid 37386647)
139. Tashiro-Itoh T, Ichida T, Matsuda Y, et al. Metallothionein expression and concentrations of copper and zinc are associated with tumor differentiation in hepatocellular carcinoma. Liver. 1997 ; 17: 300-306 (Pubitemid 28014679)
140. Gurusamy K, Davidson BR. Trace element concentration in metastatic liver disease: a systematic review. J Trace Elem Med Biol. 2007 ; 21: 169-177 (Pubitemid 47241217)
141. Al-Ebraheem A, Farquharson MJ, Ryan E. The evaluation of biologically important trace metals in liver, kidney and breast tissue. Appl Radiat Isot. 2009 ; 67: 470-474
142. Kubo S, Fukuda H, Ebara M, et al. Evaluation of distribution patterns for copper and zinc in metallothionein and superoxide dismutase in chronic liver diseases and hepatocellular carcinoma using high-performance liquid chromatography (HPLC). Biol Pharm Bull. 2005 ; 28 (7). 1137-1141 (Pubitemid 41327574)
143. Franklin RB, Levy BA, Zou J, et al. ZIP14 zinc transporter downregulation and zinc depletion in the development and progression of hepatocellular cancer. J Gastrointest Cancer. 2011 ;:
144. Taylor KM, Morgan HE, Johnson A, Nicholson RI. Structure-function analysis of a novel member of the LIV-1 subfamily of zinc transporters, ZIP14. FEBS Lett. 2005 ; 579: 427-432 (Pubitemid 40092422)
145. Franklin RB, Costello LC. Zinc as an anti-tumor agent in prostate cancer and in other cancers. Arch Biochem Biophys. 2007 ; 463: 211-217 (Pubitemid 47030335)
146. Weaver BP, Zhang Y, Hiscox S, et al. Zip4 (Slc39a4) expression is activated in hepatocellular carcinomas and functions to repress apoptosis, enhance cell cycle and increase migration. PLoS One. 2010 ; 5 (10). e13158